All In Biotech

Drug Trial Radar · NCT03573960

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

Prospective Single Arm Post Marketing Phase IV Study to Assess the Safety and Efficacy of Lenvatinib in Subjects With Locally Recurrent or Metastatic, Progressive, Radioiodine Refractory Differentiated Thyroid Cancer

Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Apr 1, 2018

Primary completion

Sep 4, 2025

Study completion Sep 4, 2025

Sponsor

Sponsor type
Industry
First posted
Jun 29, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety of lenvatinib in participants with recurrent, metastatic radio-iodine refractory differentiated thyroid cancer (DTC).

Conditions

  • Thyroid Neoplasms

Interventions

  • LenvatinibDrug

    Lenvatinib capsules.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Grade 2 or Higher Treatment-emergent Adverse EventsTime frame: Baseline up to Week 24
  2. Number of Dose ReductionsTime frame: Baseline up to Week 24
  3. Median Time to First Dose ReductionTime frame: Baseline up to Week 24

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Tata Memorial Hospital

    Mumbai, India

  • BL Kapoor Hospital, New Delhi

    New Delhi, India

  • Indrayani Hospital, Alandi

    Pune, India

  • City Cancer Centre

    Vijayawada, India

  • Shetty's Hospital

    Bangalore, Karnataka, India

  • Regional Cancer Centre, RCC, Thiruvananthapuram

    Thiruvananthapuram, Kerala, India

  • Deenanath Mangeshkar Hospital

    Pune, Maharashtra, India

  • All India Institute of Medical Sciences

    New Delhi, National Capital Territory of Delhi, India

  • Indraprastha Apollo Hospital

    New Delhi, National Capital Territory of Delhi, India

  • All India Institute of Medical Sciences

    Bhubaneswar, Odisha, India

  • S. P. Medical College & A. G. Hospitals

    Bikaner, Rajasthan, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.